Evidence map›Paper›PMID 36437479›Full record

ArticleHuman genomics2022

The integration of large-scale public data and network analysis uncovers molecular characteristics of psoriasis.

Antonio Federico, Alisa Pavel, Lena Möbus, David McKean, Giusy Del Giudice, Vittorio Fortino, Hanna Niehues, Joe Rastrick, Kilian Eyerich, Stefanie Eyerich and 5 more

Open access · goldAbstract read
In one paragraph

Article in Human genomics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Multi-Omics Research Strategies for Psoriasis and Atopic Dermatitis.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 5 countries.

Antonio FedericoFaculty of Medicine and Health Technology, Tampere University, Kauppi Campus, Arvo Ylpön Katu 34, 33520, Tampere, Finland.
Alisa PavelFaculty of Medicine and Health Technology, Tampere University, Kauppi Campus, Arvo Ylpön Katu 34, 33520, Tampere, Finland.
Lena MöbusFaculty of Medicine and Health Technology, Tampere University, Kauppi Campus, Arvo Ylpön Katu 34, 33520, Tampere, Finland.
David McKeanSanofi Immunology and Inflammation Research Therapeutic Area, Precision Immunology Cluster, Cambridge, Massachusetts, USA.
Giusy Del GiudiceFaculty of Medicine and Health Technology, Tampere University, Kauppi Campus, Arvo Ylpön Katu 34, 33520, Tampere, Finland.
Vittorio FortinoInstitute of Biomedicine, University of Eastern Finland, Kuopio, Finland.
Hanna NiehuesDepartment of Dermatology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
Joe RastrickImmunology Therapeutic Area, UCB Pharma, Slough, UK.
Kilian EyerichDepartment of Dermatology and Allergy, Technical University of Munich, Munich, Germany.
Stefanie EyerichZAUM-Center of Allergy and Environment, Technical University and Helmholtz Center Munich, Munich, Germany.
Ellen van den BogaardDepartment of Dermatology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
Catherine SmithSt. John's Institute of Dermatology, King's College London, London, UK.
Stephan WeidingerDepartment of Dermatology, Kiel University, 24105, Kiel, Germany.
Emanuele de RinaldisSanofi Immunology and Inflammation Research Therapeutic Area, Precision Immunology Cluster, Cambridge, Massachusetts, USA.
Dario GrecoFaculty of Medicine and Health Technology, Tampere University, Kauppi Campus, Arvo Ylpön Katu 34, 33520, Tampere, Finland. dario.greco@tuni.fi.
Tampere University · FIHelmholtz Zentrum München · DEKiel University · DEKing's College London · GBRadboud Institute for Molecular Life Sciences · NLRadboud University Medical Center · NLTampere University of Applied Sciences · FITechnical University of Munich · DEUCB Pharma (United Kingdom) · GBUniversity of Eastern Finland · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, a growing interest in the characterization of the molecular basis of psoriasis has been observed. However, despite the availability of a large amount of molecular data, many pathogenic mechanisms of psoriasis are still poorly understood. In this study, we performed an integrated analysis of 23 public transcriptomic datasets encompassing both lesional and uninvolved skin samples from psoriasis patients. We defined comprehensive gene co-expression network models of psoriatic lesions and uninvolved skin. Moreover, we curated and exploited a wide range of functional information from multiple public sources in order to systematically annotate the inferred networks. The integrated analysis of transcriptomics data and co-expression networks highlighted genes that are frequently dysregulated and show aberrant patterns of connectivity in the psoriatic lesion compared with the unaffected skin. Our approach allowed us to also identify plausible, previously unknown, actors in the expression of the psoriasis phenotype. Finally, we characterized communities of co-expressed genes associated with relevant molecular functions and expression signatures of specific immune cell types associated with the psoriasis lesion. Overall, integrating experimental driven results with curated functional information from public repositories represents an efficient approach to empower knowledge generation about psoriasis and may be applicable to other complex diseases.

Indexed as

PsoriasisGene Regulatory NetworksHumansSkinTranscriptomeBiomarkersDruggabilityNetwork analysisPsoriasisPublic dataTranscriptomics

Identifiers

PMID36437479
PMCPMC9703794
OpenAlexW4310028660

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.